May 31, 2000Warner Lambert Recalls
Certain Lots of Zantac
Plains, NJ (SafetyAlerts) - The Food
and Drug Administration (FDA) today reported that the Consumer Healthcare Division of
Warner-Lambert is recalling Zantac (Ranitidine Tablets), 75 mg, 4 tablet units, OTC acid
reducer, manufactured by Glaxo Wellcome, because the product fails appearance of
specification due to container/packaging deviation.
The product can be identified by Lot
#8ZP1066 EXP 06/01. UPC 3-12547-68404-0.
FDA stated in its report that 10,924
cases were distributed nationwide.
This ongoing Class III recall
was initiated by the company, by letter dated April 27, 2000. This is the first
public notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-389-0
Notice of this product warning was
sent via email to SafeMail
subscribers May 31, 2000.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.